Transgene Biotek Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Sep-2023	Jun-2023	Mar-2023	Dec-2022	Sep-2022
Gross Sales	0.05	0.10	--	--	--
Excise Duty	--	--	--	--	--
Net Sales	0.05	0.10	--	--	--
Other Operating Income	--	--	--	--	--
Other Income	0.04	0.04	0.04	0.04	0.04
Total Income	0.09	0.14	0.04	0.04	0.04
Total Expenditure	0.17	0.23	0.23	0.14	0.53
PBIDT	(0.08)	(0.08)	(0.19)	(0.10)	(0.49)
Interest	0.03	0.03	0.05	0.05	0.05
PBDT	(0.11)	(0.12)	(0.23)	(0.14)	(0.53)
Depreciation	0.02	0.02	1.24	1.24	1.24
Minority Interest Before NP	--	--	--	--	--
Tax	--	--	--	--	--
Deferred Tax	--	--	--	--	--
Reported Profit After Tax	(0.13)	(0.14)	(1.47)	(1.38)	(1.77)
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	(0.13)	(0.14)	(1.47)	(1.38)	(1.77)
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	(0.13)	(0.14)	(1.47)	(1.38)	(1.77)
EPS (Unit Curr.)	(0.02)	(0.02)	(0.19)	(0.18)	(0.23)
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	75.77	75.77	75.77	75.77	75.77
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	(160)	(80)	--	--	--
PBDTM(%)	(220)	(120)	--	--	--
PATM(%)	(260)	(140)	--	--	--

QuickLinks for Transgene Biotek Ltd.